- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Tuesday, 08 March 2011
-
Current Status:
Answered by Shona Robison on 16 March 2011
To ask the Scottish Executive whether it considers that the number needed to treat (NNT) value for treatment with eculizumab is one.
Answer
That information is not held centrally.
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Tuesday, 08 March 2011
-
Current Status:
Answered by John Swinney on 16 March 2011
To ask the Scottish Executive what reduction in complaints about Scottish Water and other water companies there has been in each year since the establishment of Waterwatch Scotland.
Answer
This information is not held centrally and I have asked the Chief Officer of Waterwatch to reply to the member.
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Tuesday, 08 March 2011
-
Current Status:
Answered by Nicola Sturgeon on 16 March 2011
To ask the Scottish Executive how many of the patients who contracted Clostridium difficile at the Vale of Leven Hospital were assessed for discharge and recorded on the delayed discharge database before they were diagnosed with the infection.
Answer
This is a matter for NHS Greater Glasgow and Clyde. The information requested is not held centrally.
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Tuesday, 08 March 2011
-
Current Status:
Answered by Shona Robison on 16 March 2011
To ask the Scottish Executive what the prevalence is of paroxysmal nocturnal haemoglobinuria.
Answer
The prevalence of paroxysmal nocturnal haemoglobinuria is estimated to be 13 cases per million.
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Tuesday, 08 March 2011
-
Current Status:
Answered by John Swinney on 16 March 2011
To ask the Scottish Executive how many jobs were created in Clackmannanshire by the establishment of Waterwatch Scotland.
Answer
This information is not held centrally and I have asked the Chief Officer of Waterwatch Scotland to reply to the member.
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Tuesday, 08 March 2011
-
Current Status:
Answered by John Swinney on 16 March 2011
To ask the Scottish Executive what the level of satisfaction of consumers consulting Waterwatch Scotland has been in each year since it was established.
Answer
This information is not held centrally and I have asked the Chief Officer of Waterwatch to reply to the member.
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Tuesday, 08 March 2011
-
Current Status:
Answered by John Swinney on 16 March 2011
To ask the Scottish Executive what the cost of Waterwatch Scotland as audited was in (a) 2008-09 and (b) 2009-10 and what the estimated costs are for 2010-11.
Answer
The costs in 2008-09 and 2009-10 of Waterwatch Scotland are set out in its annual report which is laid in the Parliament annually and is available from the Scottish Parliament Information Centre. The budgeted costs of Waterwatch Scotland for 2010-11 are set out in its corporate plan which can be found at http://www.waterwatchscotland.org/publications/waterwatch-scotland-corporate-plan-2010-11/.
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Tuesday, 08 March 2011
-
Current Status:
Answered by Shona Robison on 16 March 2011
To ask the Scottish Executive whether eculizumab is part of the national medication reinsurance scheme in Scotland.
Answer
No national medication reinsurance scheme operates in Scotland. However, NHS boards do participate in the national orphan drugs risk share scheme. Eculizumab is not included in that scheme.
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Thursday, 03 March 2011
-
Current Status:
Answered by Nicola Sturgeon on 16 March 2011
To ask the Scottish Executive what its assessment is of NHS board decisions on the funding of orphan and ultra-orphan medicines not recommended by the Scottish Medicines Consortium.
Answer
The Scottish Medicines Consortium (SMC) operates independently from the Scottish Government and NHS boards are expected to follow SMC advice.
Decisions regarding the provision of NHS services are a matter for NHS boards. Where a medicine has not been recommended for use within the NHS in Scotland by the SMC, NHS boards are not expected to make it routinely available.
However, NHS boards have arrangements for clinically-led consideration of SMC not recommended medicines, including orphan medicines, for individual patients. Clinicians are responsible for clinical decisions regarding the care of individual patients.
Recent figures provided by NHS boards following freedom of information requests indicate that overall, the majority of individual patient treatment requests are approved.
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Wednesday, 02 March 2011
-
Current Status:
Answered by Nicola Sturgeon on 16 March 2011
To ask the Scottish Executive how many accident and emergency units it expects will have consultant doctors available for 24 hours per day by 2015.
Answer
NHS Scotland boards take the decisions on how to staff their accident and emergency units. Consultant support is directly available 24 hours per day, although not necessarily on site. We are aware that several boards are considering the cost-effectiveness of having consultants resident on site 24 hours per day but no decisions have yet been made.